Oxford Asset Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Oxford Asset Management’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-44,640	Closed	-$93K	–	1597
2019 Q4	$93K	Buy	44,640 +3,483	+8%	+$6.68K	﹤0.01%	1621
2019 Q3	$98K	Buy	41,157 +28,709	+231%	+$77.1K	﹤0.01%	1632
2019 Q2	$39K	Buy	+12,448	New	+$45.7K	﹤0.01%	1645
2019 Q1	–	Sell	-24,593	Closed	-$110K	–	2120
2018 Q4	$110K	Buy	+24,593	New	+$120K	﹤0.01%	1641
2018 Q3	–	Sell	-59,829	Closed	-$355K	–	2033
2018 Q2	$355K	Buy	+59,829	New	+$438K	0.01%	1450

Other funds holding SBBP

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Oxford Asset Management's SBBP Position: Q1 2020 in Review

Oxford Asset Management sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2020, closing a stake of 44,640 shares — an estimated $93K sold.

Oxford Asset Management first reported a position in SBBP in Q2 2018 and held it in 5 quarters. The position peaked at $355K in Q2 2018. 60 funds tracked by Wall St. Rank hold SBBP as of Q1 2020.

Oxford Asset Management reported no remaining Strongbridge Biopharma plc. position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 44,640 Strongbridge Biopharma plc. shares in Q1 2020, an estimated $93K.
Oxford Asset Management first reported a position in Strongbridge Biopharma plc. in Q2 2018 and held it in 5 quarters.
Oxford Asset Management's Strongbridge Biopharma plc. position peaked at $355K in Q2 2018.
60 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.